Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II study

Cancer

Volumn 67, Issue 12, 1991, Pages 2984-2987

  Ardizzoni, A ^a   Rosso, R ^a   Fusco, V ^a   Pennucci, M C ^a   Santi, L ^a   Salvati, F ^b   Cinquegrana, A ^a   De Palma, M ^a   Serrano, J ^a   Soresi, E ^c   Crippa, M ^c   Gulisano, M ^d   Castagneto, B ^e   Scagliotti, G ^f   Rinaldi, M ^g  

^a UNIVERSITY OF GENOA   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d Ospedale San Bartolo   (Italy)

^e Ospedale S Spirito Casale Monferrato   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN;

ADULT; AGED; ALOPECIA; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MALIGNANT MESOTHELIOMA; NEUROTOXICITY; PERFORMANCE; PLEURA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOXORUBICIN; FEMALE; HUMAN; ITALY; MALE; MESOTHELIOMA; MIDDLE AGE; NEOPLASM STAGING; PLEURAL NEOPLASMS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL RATE;

EID: 0025762506     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19910615)67:12<2984::AID-CNCR2820671208>3.0.CO;2-Q     Document Type: Article

References (13)

1. Benign and malignant mesothelioma
2. Malignant pleural mesothelioma: A disease unaffected by current therapeutic maneuvers
3. Malignant pleural mesothelioma treatment: The current state of the art
4. Malignant mesothelioma. The Eastern Cooperative Group (ECOG) experience
5. Phase II trial of high‐dose cisplatin in patients with malignant mesothelioma
6. Phase II trial of carboplatin in the management of malignant mesothelioma
7. Intracavitary cisplatin for malignant mesothelioma: An update (Abstr)
8. Pleuralpneumonectomy in the management of diffuse malignant mesothelioma of the pleural
9. Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma
10. 4‐epidoxorubicin in mesothelioma: A phase II study for the EORTC Lung Cancer Cooperative Group (Abstr)
11. A prospective study of detorubicin in malignant mesothelioma
12. Treatment of six cases of mesothelioma with doxorubicin and cisplatin
13. Cisplatin with adriamycin or mitomycin for malignant mesothelioma: A randomized phase II trial (Abstr)